First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal
- PMID: 7587772
- DOI: 10.1007/BF02208989
First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal
Abstract
To determine whether the first-pass metabolism (FPM) of orally consumed alcohol varies with the time of day, 12 healthy male subjects were tested with both oral and intravenous alcohol (0.3 g/kg), in the morning and evening, always 1 hr after the same standard meal. The results revealed no significant differences in FPM (81.6 +/- 11.6 vs 92.8 +/- 10.6 mg/kg) or in any other index of alcohol absorption and metabolism. Eleven subjects were also tested in the evening after treatment with cimetidine, an H2-antagonist that inhibits gastric alcohol dehydrogenase activity in vitro. Compared to baseline, cimetidine (1 g/day for eight days) significantly decreased FPM (from 100.1 +/- 8.0 to 52.6 +/- 11.4 mg/kg, P < 0.01) and increased the systemic bioavailability of alcohol (from 66 +/- 3 to 82 +/- 4%, P < 0.01), as well as peak blood alcohol concentrations (from 4.3 +/- 0.4 to 5.9 +/- 0.5 mM, P < 0.05) and areas under the curve (from 5.1 +/- 0.5 to 7.0 +/- 0.5 mM/hr, P < 0.01). The results indicate the absence of diurnal variation in FPM and suggest that patients given cimetidine should be warned of its possible interaction with alcohol regardless of the time of day.
Similar articles
-
Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists.JAMA. 1992 Jan 1;267(1):83-6. JAMA. 1992. PMID: 1727201
-
Effects of omeprazole on ethanol metabolism: an in vitro and in vivo rat and human study.Pharmacol Res. 1994 Jan-Feb;29(1):47-58. doi: 10.1016/1043-6618(94)80097-9. Pharmacol Res. 1994. PMID: 8202442
-
Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.Aliment Pharmacol Ther. 1998 Feb;12(2):141-5. doi: 10.1046/j.1365-2036.1998.00281.x. Aliment Pharmacol Ther. 1998. PMID: 9692688
-
[Effects of H2-blockers on alcohol dehydrogenase (ADH) activity].Pol Merkur Lekarski. 2008 Dec;25(150):531-3. Pol Merkur Lekarski. 2008. PMID: 19205389 Review. Polish.
-
H2-antagonists and alcohol. Do they interact?Drug Saf. 1994 Apr;10(4):271-80. doi: 10.2165/00002018-199410040-00001. Drug Saf. 1994. PMID: 7912509 Review.
Cited by
-
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.Clin Pharmacokinet. 2003;42(1):1-31. doi: 10.2165/00003088-200342010-00001. Clin Pharmacokinet. 2003. PMID: 12489977 Review.
-
H2 antagonists and blood alcohol levels.Dig Dis Sci. 1993 Mar;38(3):569-73. doi: 10.1007/BF01316517. Dig Dis Sci. 1993. PMID: 8095199 No abstract available.
-
Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.J Gen Intern Med. 1998 Sep;13(9):594-9. doi: 10.1046/j.1525-1497.1998.00181.x. J Gen Intern Med. 1998. PMID: 9754514 Free PMC article.
-
Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis.BMJ Open Gastroenterol. 2023 Feb;10(1):e001083. doi: 10.1136/bmjgast-2022-001083. BMJ Open Gastroenterol. 2023. PMID: 36808070 Free PMC article.
-
Pharmacokinetic interactions between alcohol and other drugs.Clin Pharmacokinet. 1997 Aug;33(2):79-90. doi: 10.2165/00003088-199733020-00001. Clin Pharmacokinet. 1997. PMID: 9260032 Review.